-
Tuberculosis (TB) is the second most common infectious cause of death in adults worldwide after HIV/AIDS.
-
After being enrolled in MVP Health Care's back care program for a year, the percentage of participants reporting that their back pain did not interfere with their work increased from 10.9% to 22.9%.
-
O'Mathuna DP. The A TO Z Study: Examining the efficacy of weight loss alphabet soup. Altern Ther Women's Health 2007;9(7):53-54.
-
"We know about 1 in 200 patients get admitted to hospital following outpatient surgery, but that rate can easily vary. Outpatient surgery centers are going to continue pushing the envelope, and it is imperative that patients and physicians take control back.
-
In a study recently published in The Archives of Surgery, researchers developed an outpatient surgery admission index from independent predictors of immediate hospital admission using the following point values:
-
-
Microbicide research suffered a setback earlier this year when a phase III clinical trial studying cellulose sulfate to block HIV infection was stopped prematurely because there appeared to be a higher rate of HIV infections among the study group than the control group.
-
The latest microbicide clinical trials will use antiretroviral therapy (ART), which holds both promise and more challenges for investigators.
-
The Food and Drug Administration (FDA) granted approval, on May 23, 2007, to a generic formulation of zidovudine capsules, 100 mg, manufactured by Cipla Limited, of Mumbai, India.
-
Prophylaxis against pcp remains the single most cost-effective intervention in HIV+ patients at risk. But treatment has, in some ways, become a moving target in some patients, as their CD4 count rises and falls with newer HIV therapies, medication side effects, and variable compliance.
